Literature DB >> 1313220

Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.

A D Idowu1, E B Fraser-Smith, K L Poffenberger, R C Herman.   

Abstract

The role of herpes simplex virus type 1 (HSV-1)-encoded ribonucleotide reductase (RR) has been investigated in mice and guinea pigs using a mutant from which 90% of the large subunit of the enzyme was deleted. The RR mutant was extremely impaired in its ability to induce external vaginal lesions or to cause death in mice following intracerebral, intraperitoneal, or intravaginal inoculation, or in guinea pigs following intraperitoneal or intravaginal inoculation. The RR mutant replicated poorly in the vagina of mice and guinea pigs when compared with the parental virus. Neither infectious nor latent virus was recovered from the trigeminal ganglia of mice or from the dorsal root ganglia of mice and guinea pigs after inoculation with the RR mutant. Using the polymerase chain reaction, RR mutant DNA was, nevertheless, detected in the dorsal root ganglia of guinea pigs. These studies suggest that HSV-1 RR is essential for virulence and may also play a role in the recovery of reactivatable latent virus from ganglia in both mice and guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313220     DOI: 10.1016/0166-3542(92)90048-a

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  20 in total

1.  Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.

Authors:  C R Brandt; B Spencer; P Imesch; M Garneau; R Déziel
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 2.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

3.  Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery.

Authors:  Akihisa Kato; Keiko Shindo; Yuhei Maruzuru; Yasushi Kawaguchi
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

4.  Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.

Authors:  A M Bonneau; P Kibler; P White; C Bousquet; N Dansereau; M G Cordingley
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.

Authors:  P Desai; R Ramakrishnan; Z W Lin; B Osak; J C Glorioso; M Levine
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system.

Authors:  R B Pyles; R L Thompson
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

Authors:  S Tanaka; Y Toh; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation.

Authors:  Suping Cai; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2007-12-03       Impact factor: 3.467

9.  Identification and characterization of pseudorabies virus dUTPase.

Authors:  A Jöns; T C Mettenleiter
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo.

Authors:  K L Poffenberger; A D Idowu; E B Fraser-Smith; P E Raichlen; R C Herman
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.